Tema Oncology ETF trades under ticker CANC on NASDAQ as an ETF. Use this page to review its market price, share price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US87975E7013, CUSIP 87975E701.
Tema Oncology ETF is an exchange-traded fund focused on the oncology sector, offering investors exposure to companies engaged in the research, development, and commercialization of therapies for cancer treatment. Its primary function is to track and replicate the performance of a specified index of global companies operating within the healthcare industry, particularly those specializing in oncology. Notable features of this fund include its diversified portfolio, which potentially includes biotech firms, pharmaceutical companies, and healthcare organizations involved in innovative cancer treatment methodologies. It plays a role in the financial market by providing investors with an opportunity to invest in a specific subset of the healthcare sector, enabling diversification and potential risk reduction compared to investing in individual stocks. By facilitating targeted exposure to advancements in cancer research and treatment, the Tema Oncology ETF contributes to the broader investment landscape within the healthcare field.